SCHEMBL5365533

SCHEMBL5365533

COc1ccc(-c2ccc(CCC(=O)O)nc2-c2ccc(OC)cc2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 4/20 0.51
LMNA P02545 2/20 0.51
ATM Q13315 1/20 0.51
MAPT P10636 5/20 0.51
ALDH1A1 P00352 6/20 0.48
KDM4E B2RXH2 5/20 0.48
PKM P14618 1/20 0.48
FFAR1 O14842 2/20 0.47
FFAR4 Q5NUL3 1/20 0.47
PTGDR2 Q9Y5Y4 2/20 0.46
HPGD P15428 4/20 0.46
BACE1 P56817 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
ALOX15 P16050 2/20 0.44
CASP1 P29466 2/20 0.44
HSD17B10 Q99714 2/20 0.44
PTGS2 P35354 1/20 0.44
CASP3 P42574 1/20 0.44
SENP8 Q96LD8 1/20 0.44
SENP7 Q9BQF6 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5365571 0.81 KMT2A (0.50) LMNAMAPTALDH1A1KDM4EHPGD
SCHEMBL5362511 0.80 MAOB (0.50) LMNAMAPTALDH1A1KDM4EHPGD
SCHEMBL9695238 0.80 ALDH1A1 (0.49) GAALMNAMAPTALDH1A1KDM4E
SCHEMBL5223978 0.80 GAA (0.50) GAALMNAATMMAPTALDH1A1
Hydrochloric Acid SCHEMBL9695713 0.79 MAOB (0.51) LMNAMAPTALDH1A1KDM4EHPGD
SCHEMBL8811479 0.76 ESR2 (0.51) GAALMNAATMMAPTKDM4E
SCHEMBL9291603 0.76 LTB4R (0.58) ALDH1A1FFAR1HPGD
SCHEMBL8987130 0.76 LTB4R (0.58) ALDH1A1FFAR1HPGD
Hydrochloric Acid SCHEMBL5362197 0.76 KMT2A (0.51) LMNAMAPTALDH1A1KDM4EHPGD
SCHEMBL5358033 0.74 KMT2A (0.47) LMNAALDH1A1KDM4EHPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7271266-B2 Substituted 2,3-diphenyl pyridines MERCK & CO., INC. (US) 2007-09-18 US disclosed
US-20050182103-A1 Substituted 2,3-diphenyl pyridines MERCK SHARP & DOHME CORP. 2005-08-18 US disclosed
EP-1492784-A2 SUBSTITUTED 2,3-DIPHENYL PYRIDINES Merck & Co., Inc. (US) 2005-01-05 EP disclosed
WO-2003082191-A2 SUBSTITUTED 2,3-DIPHENYL PYRIDINES MERCK & CO., INC. (US) 2003-10-09 WO disclosed
WO-1992002513-A1 HETEROCYCLIC COMPOUNDS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1992-02-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050182103-A1 Substituted 2,3-diphenyl pyridines CNR1, CNR2, MAG GAA 2103/4885LMNA 2024/4885ATM 3666/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.